Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Athenex Inc (NQ: ATNX )

3.750 USD -0.230 (-5.78%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 23, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,285,643
Open 4.010
Bid (Size) 3.750 (32)
Ask (Size) 3.770 (1)
Prev. Close 3.980
Today's Range 3.750 - 4.053
52wk Range 3.660 - 15.24
Shares Outstanding 93,512,700
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Athenex to Provide Corporate and Financial Update for the Second Quarter 2021 on August 5, 2021
From GlobeNewswire News Releases
Athenex Announces European Commission Approval of Klisyri® (tirbanibulin) for the Topical Treatment of Actinic Keratosis
From GlobeNewswire News Releases

Performance

YTD
-66.87%
-66.87%
1 Month
-22.52%
-22.52%
3 Month
-6.95%
-6.95%
6 Month
-69.71%
-69.71%
1 Year
-68.25%
-68.25%

More News

Read More
Athenex Provides Update from FDA Type A Meeting Regarding Oral Paclitaxel Plus Encequidar for the Treatment of Metastatic Breast Cancer
From GlobeNewswire News Releases
Lifshitz Law Firm, P.C. Announces Investigations of Athenex, Inc. (NasdaqGS:ATNX), Canoo, Inc. (NasdaqGS: GOEV), Ebix, Inc. (NasdaqGS: EBIX), and Intrusion, Inc. (NasdaqCM: INTZ)
From GlobeNewswire News Releases
Athenex Presents Data on Oral Docetaxel and Oral Paclitaxel at ASCO2021 Virtual Scientific Program
From GlobeNewswire News Releases
Athenex Announces Klisyri® (tirbanibulin) Receives Positive CHMP Opinion from the European Medicines Agency (EMA) for the Treatment of Actinic Keratosis of the Face or Scalp
From GlobeNewswire News Releases
SHAREHOLDER ALERT: Robbins LLP is Investigating Athenex, Inc. (ATNX) for Shareholders
From Business Wire News Releases
Increased R&D Activities Have Fueled Growth and Promise for Pancreatic Cancer Treatment
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Increased R&D Activities Have Fueled Growth and Promise for Pancreatic Cancer Treatment
From PR Newswire
Athenex, Texas Children’s Cancer Center, and the Center for Cell and Gene Therapy at Baylor College of Medicine Present New Clinical Data on GD2 CAR-NKT Cells in Neuroblastoma at ASGCT Annual Meeting
From GlobeNewswire News Releases
Athenex Issues Update On Oral Paclitaxel Application In Metastatic Breast Cancer
Tags ATNX Benzinga General
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.